News

Press Releases

2025

25 April, 2025
T-knife Therapeutics Presents Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting Demonstrating a Potential Best-in-Class PRAME Targeted TCR-T Therapy  

25 March, 2025
T-knife Therapeutics Announces Five Presentations at American Association for Cancer Research (AACR) Annual Meeting

20 February, 2025
T-knife Therapeutics Welcomes Dr. Sophie Papa to its Board of Directors

12 February, 2025
T-knife Therapeutics to Participate in Two Investor Conferences in March

2023

27 September, 2023
T-knife Therapeutics Announces Four Presentations at the Upcoming Society for Immunotherapy of Cancer (SITC) Annual Meeting

2022

08 ApRil, 2022
T-knife Therapeutics Announces New TCR-T Program Targeting KRAS G12V and Presents Data at the American Association for Cancer Research (AACR) Annual Meeting

2021

30 Nov, 2021
T-knife Therapeutics Appoints Biotech Industry Veteran Laura Brege to its Board of Directors

01 OCT, 2021
T-knife Therapeutics Announces Upcoming Presentations at Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting

04 AUG, 2021
T-knife Therapeutics Appoints Peggy Sotiropoulou, Ph.D. as Chief Scientific Officer

02 AUG, 2021
T-knife Therapeutics Announces $110 Million Series B Financing to Advance Pipeline of T-cell Receptor Therapies

19 JAN, 2021
T-knife Announces Appointment of Thomas M. Soloway as Chief Executive Officer and Camille A. Landis as Chief Business Officer & Chief Financial Officer

Media Contact

If you are a member of the media and would like to speak with T-knife, please contact us at media@t-knife.com.